Functional characterization of liver enhancers that regulate drug-associated transporters.
about
Massively parallel functional dissection of mammalian enhancers in vivo.Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model.Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways.Pharmacogene regulatory elements: from discovery to applicationsGenome-wide study of methotrexate clearance replicates SLCO1B1.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerA novel test for selection on cis-regulatory elements reveals positive and negative selection acting on mammalian transcriptional enhancers.SUGP1 is a novel regulator of cholesterol metabolism.Sequence signatures extracted from proximal promoters can be used to predict distal enhancersDrug-induced liver injury: the role of drug metabolism and transport.Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.Pharmacogenetics of childhood acute lymphoblastic leukemia.In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus.The hydrodynamic tail vein assay as a tool for the study of liver promoters and enhancers.ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression.Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity.
P2860
Q34174436-307E9B04-D397-4A4E-AD13-99D716CBB4AAQ34871025-723C73C0-39AD-4383-A4FB-03F51B1143FFQ35176534-C9B19128-C1FF-48CC-8373-337B74EFD8B4Q36424755-EECA881F-20D8-43F6-920F-DCE271BC46A9Q36595293-8FE43E19-1FFE-48B3-9EA9-AF0BC8572D15Q36956156-1FA49DB9-4E6E-4111-85FD-E28092566EB0Q37256708-B04D31CB-FF6E-429D-94B8-9EEA575F4D2EQ37530100-73962093-E7B5-4698-BD86-F134F89FE38AQ37697916-B7A60964-9AAE-43AD-AA39-2D81E9B28301Q38084215-3C0CC1B1-81C9-47D6-AA43-DAFDAE19B057Q38185270-9E3E17BE-562E-4C02-85C1-9E683BB165F2Q38243175-92C27BE8-85C3-486E-8F35-D67A00727E7BQ38730592-3A3107A1-AA7B-466E-8238-1B169A685AA7Q42115595-A684719A-971E-4962-9915-2ABCC39D51C6Q46418563-9E209409-CECC-475F-BABD-FDB601774318Q51749326-9E8AE210-3A49-40E3-B15D-30AC4B7C804F
P2860
Functional characterization of liver enhancers that regulate drug-associated transporters.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Functional characterization of ...... drug-associated transporters.
@ast
Functional characterization of ...... drug-associated transporters.
@en
type
label
Functional characterization of ...... drug-associated transporters.
@ast
Functional characterization of ...... drug-associated transporters.
@en
prefLabel
Functional characterization of ...... drug-associated transporters.
@ast
Functional characterization of ...... drug-associated transporters.
@en
P2093
P2860
P50
P356
P1476
Functional characterization of liver enhancers that regulate drug-associated transporters
@en
P2093
D L Kroetz
H Fukushima
J L Eshragh
K M Giacomini
M V Relling
R A Castro
P2860
P304
P356
10.1038/CLPT.2010.353
P407
P577
2011-03-02T00:00:00Z